Mark Tankard

Mark Tankard has a wide range of experience in the pharmaceutical industry. Mark has worked as a Client Programme Director at Oxford Biomedica since 2019. Prior to that, they were a Program Manager at Lonza Biologics PLC, where they oversaw the preparation of monoclonal antibodies and recombinant proteins. Before that, they worked as a Senior Team Leader at Almac, providing drug development services for small molecules and peptides. Mark also served as a Director at MFT Management and Training, overseeing technical and operational solutions for the pharmaceutical industry. In addition, Tankard has experience as a Director of Operations at PhosphonicS, a VC funded spin-out from the University of London, and as a Director of Laboratory Production at Aptuit, a pharmaceutical services company. Mark also worked at Evotec, first as a Custom Preparation Manager and later as Vice-President of Laboratory Production.

Mark Tankard completed their education in a chronological order. From 1986 to 1989, they attended the University of Nottingham, where they pursued a PhD in Organic Chemistry with a specialization in Natural Product Synthesis. Following this, there is no further information regarding their education history, except for the mention that they were associated with the University of Geneva at some point. However, specific details regarding their degree, field of study, and the duration of their time at the University of Geneva are unknown.